These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38329092)

  • 1. Remote programming in stage I sacral neuromodulation: a multicentre prospective feasibility study.
    Jing J; Meng L; Zhang Y; Wang X; Zhu W; Wang Q; Lu L; Song W; Zhang Y; Li Y; Ning J; Wang H
    Int J Surg; 2024 Apr; 110(4):2104-2114. PubMed ID: 38329092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary analysis of stimulation parameters for sacral neuromodulation in different indications: a multicenter retrospective cohort study from China.
    Meng L; Yan Z; Wang X; Zhang Y; Zhu Z; Zhu W; Ling Q; Sun X; Gu Y; Lv J; Li Y
    Int J Surg; 2024 Jun; 110(6):3536-3542. PubMed ID: 38445489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Appropriate Prolonged Sacral Neuromodulation Testing in Improving Implantation Rate of a Permanent Implantable Pulse Generator in Patients with Refractory Lower Urinary Tract Dysfunctions in Mainland China.
    Zhang P; Zhang JZ; Wu LY; Zhang XD
    Chin Med J (Engl); 2017 Feb; 130(4):439-444. PubMed ID: 28218218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remotely programmed sacral neuromodulation for the treatment of patients with refractory overactive bladder: a prospective randomized controlled trial evaluating the safety and efficacy of a novel sacral neuromodulation device.
    Zhang Y; Zhang P; Tian X; Chen G; Li Y; Zhang Y; Xu Z; Wei Z; Zhang W; Ma L; Shi B; Liao L; Wang J
    World J Urol; 2019 Nov; 37(11):2481-2492. PubMed ID: 30809700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of patient sex on the effectiveness of sacral neuromodulation: A cohort study from China.
    Meng L; Tian Z; Zhang W; Zhang Y; Wang J; Liao L; Ling Q; Zhang P; Wei Z; Zhong T; Xu Z; Wen W; Li J; Luo D
    Int J Surg; 2020 Dec; 84():13-17. PubMed ID: 33080412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sacral neuromodulation for lower urinary tract dysfunction.
    Van Kerrebroeck PE; Marcelissen TA
    World J Urol; 2012 Aug; 30(4):445-50. PubMed ID: 21989816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12-month results from the RELAX-OAB study.
    Blok B; Van Kerrebroeck P; de Wachter S; Ruffion A; Van der Aa F; Jairam R; Perrouin-Verbe MA; Elneil S
    Neurourol Urodyn; 2019 Feb; 38(2):689-695. PubMed ID: 30592526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of Sacral Neuromodulation in Patients With Underlying Neurologic Lower Urinary Tract Dysfunction and Fecal Incontinence.
    Schwarztuch Gildor O; Neheman A; Vainrib M
    Urology; 2024 Jun; 188():54-62. PubMed ID: 38417466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Internet+-based Tsinghua PINS Remote Tech to improve sacral neuromodulation programming procedure.
    Zhang P; Zhang YG; Liao LM; Shen JW; Yang YB; Zhang JZ; Wu LY; Zhang XD
    Int Urol Nephrol; 2019 Apr; 51(4):627-632. PubMed ID: 30810883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the Correlation Between the Clinical Effect of Sacral Neuromodulation and Patient Age: A Retrospective Multicenter Study in China.
    Meng L; Zhang W; Zhang Y; Wang J; Liao L; Chen G; Ling Q; Zhang P; Wei Z; Chen Q
    Neuromodulation; 2020 Dec; 23(8):1189-1195. PubMed ID: 32196813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral electrical pudendal nerve stimulation as additional therapy for lower urinary tract dysfunction when stage II sacral neuromodulator fails: a case report.
    Chen S; Wang S; Gao Y; Lu X; Yan J; Xuan L; Wang S
    BMC Urol; 2021 Mar; 21(1):37. PubMed ID: 33691669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does sacral neuromodulation lead to relevant reduction in the need for intermittent catheterization? A single-center experience on patients with chronic urinary retention.
    Denzinger S; Nowrotek A; Weingart P; Burger M; Wieland WF; Rößler W; Otto W
    Neuromodulation; 2012; 15(6):586-91; discussion 591. PubMed ID: 22672285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sacral Neuromodulation in Patients With Neurogenic Lower Urinary Tract Dysfunction: A Multicenter Retrospective Study From China.
    Masood I; Chen Q; Li J; Xu Z; Ying X; Wang Y; Chen G; Liao L
    Neuromodulation; 2021 Oct; 24(7):1278-1283. PubMed ID: 33908130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sacral neuromodulation as second-line treatment strategy for lower urinary tract symptoms of various aetiologies: experience of a German high-volume clinic].
    Otto W; Nowrotek A; Burger M; Wieland WF; Rößler W; Denzinger S
    Aktuelle Urol; 2012 May; 43(3):162-6. PubMed ID: 22639025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of sacral neuromodulation for urinary indications. A Danish prospective study during the initial 15 months of a new service in a tertiary referral hospital.
    Kobberø H; Andersen M; Andersen K; Pedersen TB; Poulsen MH
    Scand J Urol; 2022; 56(5-6):404-411. PubMed ID: 36085579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with Sacral Neuromodulation: What Are the Factors Affecting Their Therapy Satisfaction?
    Banakhar M; Hassouna M
    Urol Int; 2019; 103(4):450-453. PubMed ID: 31574517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year outcomes of the ARTISAN-SNM study with the Axonics System for the treatment of urinary urgency incontinence.
    Benson K; McCrery R; Taylor C; Padron O; Blok B; de Wachter S; Pezzella A; Gruenenfelder J; Pakzad M; Perrouin-Verbe MA; Van Kerrebroeck P; Mangel J; Peters K; Kennelly M; Shapiro A; Lee U; Comiter C; Mueller M; Goldman H; Lane F
    Neurourol Urodyn; 2020 Jun; 39(5):1482-1488. PubMed ID: 32339339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis.
    Kessler TM; La Framboise D; Trelle S; Fowler CJ; Kiss G; Pannek J; Schurch B; Sievert KD; Engeler DS
    Eur Urol; 2010 Dec; 58(6):865-74. PubMed ID: 20934242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensing in Sacral Neuromodulation: A Feasibility Study in Subjects With Urinary Incontinence and Retention.
    Goudelocke C; Jungbauer Nikolas LM; Bittner KC; Offutt SJ; Miller AE; Slopsema JP
    Neuromodulation; 2024 Feb; 27(2):392-398. PubMed ID: 37589643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-Year Outcomes of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: A Randomized Trial.
    Amundsen CL; Komesu YM; Chermansky C; Gregory WT; Myers DL; Honeycutt EF; Vasavada SP; Nguyen JN; Wilson TS; Harvie HS; Wallace D;
    Eur Urol; 2018 Jul; 74(1):66-73. PubMed ID: 29482936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.